News
Study Finds No Increased MACE Risk for JAK Inhibitors in Patients With Atopic Dermatitis
The analysis looked at treatment with the upadacitinib and abrocitinib (Cibinqo), both approved for treating AD in...
News
Topical JAK Inhibitor Effective for Hand Eczema, Two Studies Suggest
Delgocitinib cream, currently under FDA review for chronic hand eczema, was recently approved in Europe for treating adults with moderate to...
News
Total Hip Replacement Superior to Exercise Therapy for Improving Hip Osteoarthritis Pain and Function
Greater improvement in patient-reported hip pain and function at 6 months was achieved with total hip replacement than with resistance training in...
News
New Cosmeceutical as Effective as Cysteamine for Facial Melasma
The product is a "new potent melanogenesis inhibitor that exhibits a unique mode of action while preserving melanocyte integrity," said Mukta...
News
Study Supports Efficacy of Home-Based Phototherapy for Psoriasis
"Efforts are needed to make home and office phototherapy more available to patients," the lead author said.
News
Sjögren Disease Treatments in Early Trials Have Mostly Positive Results
Positive results were reported from the DAHLIAS study of nipocalimab, the TWINSS study of iscalimab, and a phase 1 trial of tibulizumab, but it...
News
Future of Lupus Treatments Looks Brighter With Multiple Promising Therapeutic Approaches
Data presented at EULAR 2024 suggest that there are positive times ahead for the treatment of systemic lupus erythematosus, with experts...
News
Debate Over Axial Involvement in Psoriatic Arthritis Still Unresolved Despite New Studies
Data from two studies corroborated what was already known about axial psoriatic arthritis rather than help define or differentiate it further from...
News
Patient-Driven Care Plus Telemonitoring Yields Promising Results for Spondyloarthritis
Patient-initiated care with or without remote monitoring for spondyloarthritis has been shown to work just as well as usual face-to-face care in...
News
Latest Izokibep Trial for PsA Shows Promise But Misses on Enthesitis
The primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce enthesitis more than placebo, as might have been...
News
Selective JAK 1 Inhibitor for RA Proves Promising in Phase 3 Trial
SHR0302 (ivarmacitinib) is highly selective for JAK 1 and the first JAK inhibitor to be originally developed and now tested in a phase 3 RA...
News
Upadacitinib Proves Successful in First JAK Inhibitor Trial for Giant Cell Arteritis
Results from the SELECT-GCA study showed that upadacitinib (Rinvoq) induced significant and sustained remission in people with new-onset or...
News
EULAR 2024 Preview: Therapeutics in Development Take Center Stage
Experts give their top picks and hot tips on data being presented at the upcoming European Congress of Rheumatology taking place on June 12-15 in...
News
What Does Natural Healing of ACL Ruptures Mean for Long-Term Outcomes?
Evidence mounts that the anterior cruciate ligament may heal without surgery, but the long-term outcomes are only beginning to be evaluated.
News
Will Diabetes Drugs Advance Osteoarthritis Management?
Researchers are looking to see if GLP-1 receptor agonists, DPP4 inhibitors, and SGLT2 inhibitors have beneficial effects in osteoarthritis.